Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted ...

Based on the study's promising results, Immunome intends to submit a New Drug Application to the U.S. Food and Drug ...

The pivotal phase 3 RINGSIDE trial investigated varegacestat, an oral gamma secretase inhibitor, in patients with progressing desmoid tumors.

The dreaded norovirus—the "vomiting bug" that often causes stomach flu symptoms—is climbing again in California, and doctors ...

Immunome shares trade higher on Monday after the company announced results from the global pivotal Phase 3 RINGSIDE trial of varegcasetat and met its primary endpoint.

Ringside’s phase 3 findings reveal the potential varegacestat has to deliver “best-in-class results in a convenient, ...

Varegacestat, an investigational gamma secretase inhibitor (GSI), delivered clinically meaningful improvements in efficacy ...

Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with Conditions (NOC/c)] for Wegovy® (semaglutide injection) for the treatment ...

Immunome (IMNM) announced topline results from the global Phase 3 RINGSIDE trial of varegacestat, an investigational, oral, once-daily gamma ...

Ginger may help reduce migraine pain, nausea, and light sensitivity. It might even give your migraine meds a natural boost. Learn how to use ginger for migraines.

LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their cholesterol goals, today announced the U.S. Food and Drug ...

Flu and RSV levels remain low in Oklahoma, but schools are preparing for the usual rise in winter illnesses. Vandever ...